Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.55 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.54 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.54 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CETP | P11597 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL594176 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308645 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL16389868 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL15281949 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL10600706 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL875221 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8627798 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8623658 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308684 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL240206 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113173863-B | Preparation method of fatty acyl amino acid | 张家港格瑞特化学有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-113173863-A | Preparation method of fatty acyl amino acid | 张家港格瑞特化学有限公司 | 2021-07-27 | — | — | CN | claimed |
| EP-3846771-A1 | CLEANSING COMPOSITIONS FREE OF SODIUM CHLORIDE AND SULFATE-BASED SURFACTANTS | L'OREAL (FR) | 2021-07-14 | — | — | EP | claimed |
| CN-112638356-A | Cleaning compositions free of sodium chloride and sulfate based surfactants | 莱雅公司 | 2021-04-09 | — | — | CN | claimed |
| US-20200078284-A1 | CLEANSING COMPOSITIONS FREE OF SODIUM CHLORIDE AND SULFATE-BASED SURFACTANTS | L'OREAL (FR) | 2020-03-12 | — | — | US | claimed |
| US-9868847-B2 | Rubber composition and tire produced by using the same | BRIDGESTONE CORPORATION (JP) | 2018-01-16 | — | — | US | claimed |
| EP-2644650-B1 | RUBBER COMPOSITION AND TIRE USING THE SAME | BRIDGESTONE CORP (JP) | 2017-10-25 | — | — | EP | claimed |
| WO-2013189037-A1 | PEARLESCENT CONDITIONING COMPOSITION AND METHOD FOR PREPARING THE SAME | L'OREAL (FR) | 2013-12-27 | — | — | WO | claimed |
| US-20130317151-A1 | RUBBER COMPOSITION AND TIRE PRODUCED BY USING THE SAME | KAO CORPORATION (JP) | 2013-11-28 | — | — | US | claimed |
| US-8350080-B2 | Method for the production of acyl glycinates by means of direct oxidation | CLARIANT FINANCE (BVI) LIMITED (BV) | 2013-01-08 | — | — | US | claimed |
| EP-0723576-A1 | LIQUID DETERGENT COMPOSITIONS COMPRISING SALTS OF ALPHA SULFONATED FATTY ACID METHYL ESTERS, AND ANIONIC SURFACTANTS | STEPAN COMPANY (US) | 1996-07-31 | — | — | EP | claimed |
| WO-1995010585-A1 | LIQUID DETERGENT COMPOSITIONS COMPRISING SALTS OF ALPHA SULFONATED FATTY ACID METHYL ESTERS, AND ANIONIC SURFACTANTS | STEPAN COMPANY (US) | 1995-04-20 | — | — | WO | claimed |
| US-5017305-A | Fatty Acid Ester, Fatty Acid Monoethanolamide, And An Ether Carboxylic Acid As Emulsifier | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1991-05-21 | — | — | US | claimed |
| US-4948528-A | CONTAINING ESTER, FATTY ACID MONOETHANOLAMIDE, ALKYLGLUCOSIDE EMULSIFIER | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1990-08-14 | — | — | US | claimed |
| US-4824594-A | Free-flowing pearlescent concentrate | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1989-04-25 | — | — | US | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| US-4777038-A | NONIONIC, STORAGE-STABLE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1988-10-11 | — | — | US | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |
| US-4039562-A | MALEIC ANHYDRIDE, FATTY ALCOHOL, ALKALI METAL SULFITE | REWO CHEMISCHE WERKE G.M.B.H. (DT) | 1977-08-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200078284-A1 | CLEANSING COMPOSITIONS FREE OF SODIUM CHLORIDE AND SULFATE-BASED SURFACTANTS | ACR, STS, SCNN1G | FAAH 4565/4885MEN1 287/4885KMT2A 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.